1. Home
  2. VNDA vs TATT Comparison

VNDA vs TATT Comparison

Compare VNDA & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • TATT
  • Stock Information
  • Founded
  • VNDA 2002
  • TATT 1985
  • Country
  • VNDA United States
  • TATT Israel
  • Employees
  • VNDA N/A
  • TATT N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • TATT Aerospace
  • Sector
  • VNDA Health Care
  • TATT Industrials
  • Exchange
  • VNDA Nasdaq
  • TATT Nasdaq
  • Market Cap
  • VNDA 237.9M
  • TATT 308.2M
  • IPO Year
  • VNDA 2006
  • TATT 1987
  • Fundamental
  • Price
  • VNDA $4.22
  • TATT $34.74
  • Analyst Decision
  • VNDA Strong Buy
  • TATT Strong Buy
  • Analyst Count
  • VNDA 2
  • TATT 1
  • Target Price
  • VNDA $16.50
  • TATT $35.00
  • AVG Volume (30 Days)
  • VNDA 500.0K
  • TATT 137.7K
  • Earning Date
  • VNDA 05-07-2025
  • TATT 05-21-2025
  • Dividend Yield
  • VNDA N/A
  • TATT N/A
  • EPS Growth
  • VNDA N/A
  • TATT 96.08
  • EPS
  • VNDA N/A
  • TATT 1.00
  • Revenue
  • VNDA $201,351,000.00
  • TATT $152,116,000.00
  • Revenue This Year
  • VNDA $14.36
  • TATT $18.62
  • Revenue Next Year
  • VNDA $44.53
  • TATT $10.62
  • P/E Ratio
  • VNDA N/A
  • TATT $31.80
  • Revenue Growth
  • VNDA 13.37
  • TATT 33.68
  • 52 Week Low
  • VNDA $3.85
  • TATT $11.84
  • 52 Week High
  • VNDA $6.75
  • TATT $33.83
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 41.17
  • TATT 72.03
  • Support Level
  • VNDA $4.20
  • TATT $28.58
  • Resistance Level
  • VNDA $4.64
  • TATT $33.83
  • Average True Range (ATR)
  • VNDA 0.17
  • TATT 2.17
  • MACD
  • VNDA 0.01
  • TATT 0.59
  • Stochastic Oscillator
  • VNDA 20.75
  • TATT 95.68

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Share on Social Networks: